# US 2013/0095229 A1 · Method of forming dextran and thrombin sheets

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0095229 A1
- Document ID: US20130095229A1
- Status: Published application
- Kind: A1
- Application number: 13/622,604
- Filed: 2012-09-19
- Published: 2013-04-18
- Earliest claimed: 2011-10-18
- Assignees: St. Teresa Medical, Inc.
- Inventors: Curtis E. Olson; Philip A. Messina; Brian Jeffrey Jackson
- Web page: https://patentgrep.com/patent/US20130095229A1

## CPC

- A61L 15/44: Medicaments
- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K 38/363: {Fibrinogen}
- A61K 38/4833: {Thrombin (3.4.21.5)}
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- C12Y 304/21005: Thrombin (3.4.21.5)
- A61K 49/00: Preparations for testing in vivo
- A61L 2300/418: Agents promoting blood coagulation, blood-clotting agents, embolising agents
- A61L 2400/04: Materials for stopping bleeding
- A61M 5/00: Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests (tube connectors, tube couplings, valves or branch units, specially adapted for medical use A61M39/00; containers specially adapted for medical or pharmaceutical purposes A61J1/00)
- A61M 25/02: Holding devices, e.g. on the body
- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Y: ENZYMES
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A method of forming hemostatic sheets. Dextran and water are mixed to form a dextran-water mixture. The dextran-water mixture is formed into a first support layer. Fibrinogen and thrombin are mixed to form a fibrinogen and thrombin mixture. The fibrinogen and thrombin mixture is dispersed on the first support layer to form a hemostatic sheet.

## Claims

### Claim 1

A method of forming hemostatic sheets comprising:
mixing dextran and water to form a dextran-water mixture;
forming the dextran-water mixture into a first support layer;
mixing fibrinogen and thrombin to form a fibrinogen and thrombin mixture; and
dispersing the fibrinogen and thrombin mixture on the first support layer for form a hemostatic sheet.

### Claim 2 (depends on 1)

The method of claim 1, the dextran is mixed with the water at a concentration of between about 3 and 9 grams of dextran to about 6 milliliters of water.

### Claim 3 (depends on 1)

The method of claim 1, and further comprising mixing at least a portion of the thrombin into the dextran-water mixture prior to forming the dextran-water mixture into the first support layer.

### Claim 4 (depends on 1)

The method of claim 1, wherein the first support layer has a relatively uniform thickness.

### Claim 5 (depends on 1)

The method of claim 1, wherein the thrombin is salmon thrombin and wherein the fibrinogen is salmon fibrinogen.

### Claim 6 (depends on 1)

The method of claim 1, wherein forming the first support layer comprises electrospinning the dextran-water mixture to form a fiber and depositing the fibers are least partially on top of each other.

### Claim 7 (depends on 1)

The method of claim 1, and further comprising compressing the first support layer to a height that is less than an initial height of the first support layer, wherein the compression causes the height of the first support layer to be reduced by at least 75 percent compared to the initial height of the first support layer.

### Claim 8 (depends on 1)

The method of claim 1, and further comprising placing a retaining mechanism over a surface of the hemostatic sheet on which the fibrinogen and thrombin mixture has been dispersed, wherein the retaining mechanism retains the fibrinogen and thrombin mixture on the hemostatic sheet.

### Claim 9 (depends on 8)

The method of claim 8, wherein the retaining mechanism is a second support layer having a configuration that is similar to the first support layer.

### Claim 10 (depends on 1)

The method of claim 1, and further comprising dispensing at least one bioactive agent on the hemostatic sheet.

### Claim 11 (depends on 1)

The method of claim 1, wherein the first support layer is formed on a support material and wherein the support material comprises a material selected from the group consisting of gauze, compressed electrospun dextran, polyglycolytic acid polymers, polylactic acid polymers, caprolactone polymers and charged nylon.

### Claim 12

A method of forming hemostatic sheets comprising:
mixing dextran and water to form a dextran-water mixture;
mixing thrombin into the dextran-water mixture to form a dextran-thrombin-water mixture;
forming the dextran-thrombin-water mixture into a first support layer; and
dispersing fibrinogen on the first support layer for form a hemostatic sheet.

### Claim 13 (depends on 12)

The method of claim 12, the dextran is mixed with the water at a concentration of between about 3 and 9 grams of dextran to about 6 milliliters of water.

### Claim 14 (depends on 12)

The method of claim 12, and further comprising mixing at least a portion of the thrombin into the dextran-water mixture prior to forming the dextran-water mixture into the first support layer.

### Claim 15 (depends on 12)

The method of claim 12, wherein the first support layer has a relatively uniform thickness.

### Claim 16 (depends on 12)

The method of claim 12, wherein the thrombin is salmon thrombin and wherein the fibrinogen is salmon fibrinogen.

### Claim 17 (depends on 12)

The method of claim 12, wherein forming the first support layer comprises electrospinning the dextran-thrombin-water mixture to form a fiber and depositing the fibers are least partially on top of each other.

### Claim 18 (depends on 12)

The method of claim 12, and further comprising compressing the first support layer to a height that is less than an initial height of the first support layer, wherein the compression causes the height of the first support layer to be reduced by at least 75 percent compared to the initial height of the first support layer.

### Claim 19 (depends on 12)

The method of claim 12, and further comprising placing a retaining mechanism over a surface of the hemostatic sheet on which the fibrinogen has been dispersed, wherein the retaining mechanism retains the fibrinogen on the hemostatic sheet.

### Claim 20 (depends on 19)

The method of claim 19, wherein the retaining mechanism is a second support layer having a configuration that is similar to the first support layer.

### Claim 21 (depends on 12)

The method of claim 12, and further comprising dispensing at least one bioactive agent on the hemostatic sheet.

### Claim 22 (depends on 12)

The method of claim 12, wherein the first support layer is formed on a support material and wherein the support material comprises a material selected from the group consisting of gauze, compressed electrospun dextran, polyglycolytic acid polymers, polylactic acid polymers, caprolactone polymers and charged nylon.

### Claim 23

A method of forming hemostatic sheets comprising:
mixing dextran and water to form a dextran-water mixture;
electrospinning the dextran-water mixture into a first support layer; and
dispersing antibiotics, medicaments that alleviate pain, growth factors, bone morphogenic proteins, vasoactive materials, inflammation reduction steroids and combinations thereof on the first support layer for form a hemostatic sheet.
